Start with the most obvious one. The pharmaceutical industry loses, by some estimates, around $10 billion annually in markets where medical cannabis is legal. Patients substitute cannabis for opioids, sleep aids, anti-anxiety medications, and antidepressants. Not all patients, and not always — but enough to show up in the revenue reports.